- August 19, 2021
- 1:00 PM - 2:30 PM ET
- Organized By:
Sponsored by the U.S. Food & Drug Administration (FDA)
Claudia Campos Galván, MA - Chief Programs Officer and Mental Health Director at Nueva Vida, a culturally sensitive cancer support network for the Latino population
Wenora Johnson - Three-time Cancer Survivor; Lynch Syndrome Patient; Research/Patient Advocate; Navy Veteran
Steven Lemery, MD – Survivor; Medical Oncologist; Acting Associate Director of Tissue Agnostic Drug Development, Oncology Center of Excellence & Division Director, Division of Oncology 3, Office of Oncologic Diseases, FDA
Phoenix A. Matthews, PhD - Professor and Licensed Clinical Psychologist, Associate Dean for Equity and Inclusion, College of Nursing, Department of Population Health Nursing Science, University of Illinois Chicago
Margaret (Mimi) Mahon, PhD, CRNP - Pediatric and Palliative Care Nurse Practitioner, Clinical Center, National Institutes of Health
Stephanie Stern, LCSW-C - Social Worker/Program Director, Hope Connections for Cancer
Rea Blakey: Associate Director for External Outreach and Engagement, Oncology Center of Excellence, US Food and Drug Administration
Richard Pazdur, MD - OCE Director, FDA
Registration required to attend: https://fdaoce.formstack.com/forms/ocecoca081921
The FDA Oncology Center of Center of Excellence presents Conversations on Cancer - Finding Calm in the Storm: Moving Toward Physical and Emotional Wellbeing. Join this 1 ½ hour informal panel discussion exploring personal perspectives from survivors, clinicians, caregivers, and behavioral health experts on the impact of cancer.
This important discussion will cover the following:
- Behavioral health considerations from diagnosis through survivorship
- barriers and challenges that may arise when seeking support, and unique considerations for marginalized populations
- effective communication strategies between patient, caregivers, and health care team to address needs in an individualized manner
- resources supporting coping, and physical and emotional wellbeing
- OCE’s efforts to ensure cancer patient experiences are incorporated into drug development and evaluation
A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above.
FDA plans to post archived webcasts after the meeting, however, in cases where the transmission was not successful, archived webcasts will not be available.
For additional information, please send an email to: OCE-Engagement@fda.hhs.gov